Erlotinib in Advanced Pancreatic Cancer: A Viewpoint by Andrew H. Ko

By Ko Andrew H.  

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 41-42

Adis International

Access to resources Recommend Favorite

Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer

By Welch Stephen A   Moore Malcolm J  

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 247-254

Future Medicine

Access to resources Recommend Favorite

Erlotinib or capecitabine with gemcitabine in pancreatic cancer?

By de Jager Jenny   Stebbing Justin  

Future Oncology, Vol. 2, Iss. 2, 2006-04 ,pp. : 161-163

Future Medicine

Access to resources Recommend Favorite

Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer

By            

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1101-1104

Spandidos Publications

Access to resources Recommend Favorite

A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib

By Lin Po-Chou  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 140-150

Humana Press, Inc

Access to resources Recommend Favorite